Vanguard Capital Management’s Tyra Biosciences TYRA Stock Holding History
Bought
Maintained
Sold
Other funds holding TYRA
SL
Vanguard Capital Management's TYRA Position: Q3 2026 in Review
Vanguard Capital Management increased its Tyra Biosciences (TYRA) stake by 17% in Q3 2026, buying an estimated $7.14M and bringing the position to 1,768,140 shares worth $38.7M. The position accounts for ﹤0.01% of the portfolio, ranked #2036.
Vanguard Capital Management first reported a position in TYRA in Q1 2026 and has held it in 3 quarters since. The position peaked at $48.2M in Q2 2026. 155 funds tracked by Wall St. Rank hold TYRA as of Q3 2026.
- Vanguard Capital Management held 1,768,140 shares of Tyra Biosciences worth $38.7M as of Q3 2026.
- Vanguard Capital Management bought 259,693 Tyra Biosciences shares in Q3 2026, an estimated $7.14M.
- Tyra Biosciences made up ﹤0.01% of Vanguard Capital Management's portfolio in Q3 2026, its #2036 holding.
- Vanguard Capital Management first reported a position in Tyra Biosciences in Q1 2026 and has held it in 3 quarters since.
- Vanguard Capital Management's Tyra Biosciences position peaked at $48.2M in Q2 2026.
- 155 funds tracked by Wall St. Rank held Tyra Biosciences as of Q3 2026.
Based on Vanguard Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.